作者
George Ntaios, Gregory YH Lip, Konstantinos Makaritsis, Vasileios Papavasileiou, Anastasia Vemmou, Eleni Koroboki, Paraskevi Savvari, Efstathios Manios, Haralampos Milionis, Konstantinos Vemmos
发表日期
2013/3/12
期刊
Neurology
卷号
80
期号
11
页码范围
1009-1017
出版商
Lippincott Williams & Wilkins
简介
Objective
CHADS2 and CHA2DS2-VASc scores are used to assess stroke risk in patients with atrial fibrillation (AF). We investigated whether these scores are associated with stroke outcome in non-AF stroke patients.
Methods
Consecutive patients with acute first-ever ischemic stroke but without AF were classified into subgroups according to prestroke CHADS2 and CHA2DS2-VASc scores and followed up for 5 years. The end points were death, stroke recurrence, and a composite of major cardiovascular events.
Results
Among 1,756 patients (aged 67.2 ± 12.3 years, 68.2% males), there were 258 (14.7%), 617 (35.3%), and 878 (50.0%) patients with low, intermediate, and high CHADS2 score, respectively. The corresponding figures for CHA2DS2-VASc subgroups were 110 (6.3%), 255 (14.5%), and 1,391 (79.2%). There were significant differences between CHADS2 subgroups in 5-year mortality (log-rank test = 74.5 …
学术搜索中的文章
G Ntaios, GYH Lip, K Makaritsis, V Papavasileiou… - Neurology, 2013
